Acorah Software Products - Accounts Production 19.2.450 false true 31 January 2025 1 February 2024 false true No description of principal activity 1 February 2025 31 January 2026 31 January 2026 10017038 Mr Narvinder Nandra iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10017038 2025-01-31 10017038 2026-01-31 10017038 2025-02-01 2026-01-31 10017038 frs-core:CurrentFinancialInstruments 2026-01-31 10017038 frs-bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 10017038 frs-bus:FilletedAccounts 2025-02-01 2026-01-31 10017038 frs-bus:Micro-entities 2025-02-01 2026-01-31 10017038 frs-bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 10017038 frs-bus:Director1 2025-02-01 2026-01-31 10017038 2024-01-31 10017038 2025-01-31 10017038 2024-02-01 2025-01-31 10017038 frs-core:CurrentFinancialInstruments 2025-01-31
Registered number: 10017038
Nandra Pharma Ltd
Unaudited Financial Statements
For The Year Ended 31 January 2026
AMCI ASSOCIATES LTD
Balance Sheet
Registered number: 10017038
2026 2025
£ £
Fixed assets 2 2
Current assets 8,254 5,254
Creditors: Amounts Falling Due Within One Year (1,887 ) (1,557 )
NET CURRENT ASSETS 6,367 3,697
TOTAL ASSETS LESS CURRENT LIABILITIES 6,369 3,699
NET ASSETS 6,369 3,699
CAPITAL AND RESERVES 6,369 3,699

Notes

1. General Information
Nandra Pharma Ltd Registered number 10017038 is a limited by shares company incorporated in England and Wales. The Registered Office is 133 Tame Road, Birmingham, B6 7DG.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2025: 1)
1 1
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Narvinder Nandra
Director
16/02/2026